AE-4902 • Adverse Event
LYA-Onco 1 | Submitted Feb 18, 2026
Follow-up Requested
Adverse Event & Product Quality Intake
Submit safety and quality events for Lya therapies with required fields, seriousness triage, and follow-up routing.
AE/PQC intake
Seriousness triage
PV + quality routing
Submit Safety Case
Capture minimum required details for compliant submission.
Submissions are routed to pharmacovigilance and quality workflows with immutable audit trails.
Safety Case Tracker
Case-level status for office and provider follow-up requests.
PQC-3128 • Product Complaint
LYA-Neuro 3 | Submitted Feb 17, 2026
Quality Review
AE-4907 • Adverse Event
LYA-Immuno 2 | Submitted Feb 16, 2026
Closed